Immunome IMNM
NASDAQ IMNM
$20.90 +0.01 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunome (IMNM) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Immunome's Return on Capital Employed [ROCE] came in at -48.57% for Q2 2026, up 27.16 percentage points from -75.72% a year earlier but down 10.30 percentage points from the prior quarter.

Analysis

Immunome (IMNM) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Immunome's Return on Capital Employed [ROCE] was -53.78%, up 164.52 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +2.58 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -218.30% in FY2024 (-48.39 pp), -169.91% in FY2023 (-60.26 pp), -109.65% in FY2022 (-48.91 pp) and -60.74% in FY2021 (-4.38 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -264.18% (Q1 2023) to -38.27% (Q1 2026).
  • Year-over-year, Return on Capital Employed [ROCE] has increased for six consecutive quarters, with an average year-over-year change of +19.37 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2024 (a gain of 147.48 percentage points), and the weakest in Q1 2023 (a drop of 187.74 percentage points).
  • Business Quant data shows IMNM's Return on Capital Employed [ROCE] at -38.27% (Q1 2026), -50.22% (Q4 2025) and -87.92% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Immunome 2.37 Bn 341.22 Mn - -48.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48.57%
Mar 31, 2026 -38.27%
Dec 31, 2025 -50.22%
Sep 30, 2025 -87.92%
Jun 30, 2025 -75.72%
Mar 31, 2025 -83.68%
Dec 31, 2024 -157.42%
Sep 30, 2024 -133.94%
Jun 30, 2024 -101.31%
Mar 31, 2024 -116.71%
Dec 31, 2023 -110.61%
Sep 30, 2023 -51.29%
Jun 30, 2023 -144.51%
Mar 31, 2023 -264.18%
Dec 31, 2022 -184.83%
Sep 30, 2022 -134.82%
Jun 30, 2022 -104.00%
Mar 31, 2022 -76.44%
Dec 31, 2021 -49.90%
Sep 30, 2021 -38.56%
API Access

Immunome Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMNM&period=max&api_key=YOUR_API_KEY